Literature DB >> 22519374

High prevalence of hepatitis C infection among high risk groups in Kohgiloyeh and Boyerahmad Province, Southwest Iran.

Bahador Sarkari1, Owrang Eilami, Abdolmajid Khosravani, Asghar Sharifi, Marzieh Tabatabaee, Mohammad Fararouei.   

Abstract

BACKGROUND: Detection of Hepatitis C virus (HCV)-infected people in each community assists with infection prevention and control.  This study aims to evaluate the prevalence of HCV infection among high risk groups in Kohgiloyeh and Boyerahmad Province, Southwest Iran.
METHODS: This was a cross-sectional study conducted from 2009-2010 in Kohgiloyeh and Boyerahmad Province. High risk groups for HCV were the subjects of this study. Blood samples were taken from 2009 individuals at high risk for HCV that included inmates, injecting drug users (IDUs), health care workers, patients on maintenance hemodialysis, hemophilic patients, and those with histories of blood transfusions. Patients were residents of Yasuj, Gachsaran, and Dehdasht (3 main townships in the province). Samples were analyzed by ELISA for anti-HCV antibodies. Demographic features of participants were recorded by a questionnaire during sample collection. Data were analyzed by SPSS version 13 software.
RESULTS: Of 2009 subjects, HCV antibodies were detected in 172 (8.6%). Rate of infection was higher in males (11.4%) compared to females (3.2%). Rate of infection in inmates was 11.7% while this rate was 42.4% in IDUs, 4.2% in health care workers, and 6.1% in thalassemic patients. Significant correlation was found between HCV infection, history of imprisonment, and thalassemia.
CONCLUSION: Results of this study have provided epidemiologic features of HCV and its risk factors in Kohgiloyeh and Boyerahmad Province, Southwest Iran. This information may assist in preventing the spread of HCV infection in this and other similar settings in the region. The findings of this study may help in improving surveillance and infection control in the community through management and monitoring of infected individuals.

Entities:  

Mesh:

Year:  2012        PMID: 22519374     DOI: 012155/AIM.005

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  16 in total

Review 1.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  Hepatocellular carcinoma in Asia: Prevention strategy and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Afsaneh Sharifian; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-06-28

Review 3.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

4.  Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.

Authors:  Ahmed Zidan; Hubert Scheuerlein; Silke Schüle; Utz Settmacher; Falk Rauchfuss
Journal:  Hepat Mon       Date:  2012-10-24       Impact factor: 0.660

5.  Seropositivity of Hepatitis B and C among Syrian Multi-transfused Patients with Hemoglobinopathy.

Authors:  Widad Yazaji; Wafa Habbal; Fawza Monem
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-09-01       Impact factor: 2.576

Review 6.  The prevalence of hepatitis C among healthcare workers: a systematic review and meta-analysis.

Authors:  Claudia Westermann; Claudia Peters; Birgitte Lisiak; Monica Lamberti; Albert Nienhaus
Journal:  Occup Environ Med       Date:  2015-10-05       Impact factor: 4.402

7.  Prevalence and risk factors of intestinal protozoan infections: a population-based study in rural areas of Boyer-Ahmad district, Southwestern Iran.

Authors:  Bahador Sarkari; Ghasem Hosseini; Mohammad Hossein Motazedian; Mohammad Fararouei; Abdolali Moshfe
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

8.  New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology.

Authors:  Svetlana Gorodin; Serhat Unal; Youchun Wang; Mikhail I Mikhaylov; Ludmila Bigbulatova; Tamar Jehuda-Cohen
Journal:  ScientificWorldJournal       Date:  2013-02-14

9.  AIDS and hepatitis B and C high risk behaviors among 15 to 45 years old individuals in Bandar Abbas (Iran) in 2012.

Authors:  Mahin Jamshidi Makiani; Parivash Davoodian; Farshid Abedi; Mahtab Hossini; Shahram Zare; Shafea Rahimi; Keramat Allah Jahanshahi; Tasnim Eqbal Eftekhari
Journal:  Electron Physician       Date:  2014-07-01

10.  Evaluation of antibody frequency against HBV, HCV and HTLV-1.

Authors:  Seyed Mohammad Ebrahim Tahaei; Seyed Reza Mohebbi; Seyed Reza Fatemi; Pedram Azimzadeh; Dariush Mirsattari; Azar Sanati; Afsaneh Sharifian
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.